Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 8—August 2012

Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States

Edward GoldsteinComments to Author , Robert D. Kirkcaldy, David Reshef, Stuart Berman, Hillard Weinstock, Pardis Sabeti, Carlos Del Rio, Geraldine Hall, Edward W. Hook, and Marc Lipsitch
Author affiliations: Harvard School of Public Health, Boston, Massachusetts, USA (E. Goldstein, M. Lipsitch); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.D. Kirkcaldy, S. Berman, H. Weinstock); Oxford University, Oxford, UK (D. Reshef); Harvard University, Cambridge, Massachusetts, USA (P. Sabeti); Emory University, Atlanta (C. Del Rio); Cleveland Clinic, Cleveland, Ohio, USA (G. Hall); University of Alabama at Birmingham, Birmingham, Alabama, USA (E.W. Hook); and Jefferson County Department of Health, Birmingham (E.W. Hook)

Main Article


Regression coefficients and the p values for 4 groups, according to resistance type and patient’s sexual orientation

Model* β0 (95% CI) βRTH (95% CI) βM (95% CI) Hosmer-Lemeshow p value
Men who have sex with men
Triply resistant −2.48 (−2.72 to −2.24) −0.328 (−0.650 to 0.005) 0.03 (0.023 to 0.037) 0.19
Monoresistant −3.75 (−4.42 to −3.08) 0.51 (−0.18 to 1.2) 0.046 (0.006 to 0.086) 0.18
Heterosexual men
Triply resistant −4.72 (−5.08 to −4.36) 1.17 (0.81 to1.53) 0.022 (0.011 to 0.033) 0.35
Monoresistant −5.05 (−5.49 to −4.60) 0.543 (−0.02 to 1.11) 0.018 (0.005 to 0.032) 0.69

*Logistic model given by equation 1.

Main Article

Page created: July 17, 2012
Page updated: July 17, 2012
Page reviewed: July 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.